Lilly’s decision to offer vials has also been seen as its way to combat the rise in compounding. Patients have been turning ...

Popular obesity stocks fell on Tuesday after pharma giant Eli Lilly LLY lowered its sales guidance for full-year 2024 and announced disappointing preliminary fourth-quarter sales numbers. LLY’s ...